Leveraging genetic propensity to identify modifiable factors for the age at onset of Alzheimer's disease
Alzheimer's & Dementia · 2026
DOI: 10.1002/alz.71111 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Yi-Ju Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Age of Onset. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Knowledge of modifiable factors influencing age at onset (AAO) of Alzheimer's disease (AD) remains limited. This study utilizes genetic information to uncover such factors. METHODS Using 43 exposure genome‐wide association studies (GWAS) summary statistics, we calculated corresponding polygenic scores (PGS) for 9219 AD cases and 10,345 controls from the Alzheimer's Disease Genetic Consortium (ADGC). Linear mixed model and survival analyses were performed to identify exposure‐PGS associated with AAO. Top exposures were cross‐evaluated using PGS from the PGS Catalog and Mendelian randomization (MR) for causal relationships. RESULTS Eight exposures showed significant exposure‐PGS associations with AAO of AD. Higher educational attainment, better cognitive performance, and greater relative fat intake were associated with later AAO; whereas the remaining were linked to earlier onset. MR analysis indicated a causal relationship between AAO and educational attainment, cardiovascular disease, and type 2 diabetes (T2D). DISCUSSION The eight modifiable factors, particularly educational attainment, cardiovascular disease, and T2D, may facilitate early intervention to delay the onset of AD. Highlights We screened 43 modifiable factors for their association with the age at onset (AAO) of Alzheimer's disease (AD) using polygenic scores (PGS) as the proxy for the exposure. Higher educational attainment, better cognitive performance, and greater relative fat intake were linked to later AAO, suggesting an enhanced resilience against AD. Type 2 diabetes, cardiovascular disease, major coronary heart disease, and increased low‐density lipoprotein (LDL) ‐cholesterol and total cholesterol are associated with earlier AAO. Mendelian randomization analysis revealed causal effects of educational attainment, type 2 diabetes, and cardiovascular disease on AAO of AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina, USA.
- Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina, USA.
- Centre for Biomedical Data Science, Duke-NUS Medical School, Singapore, Singapore.
- Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
- John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, Florida, USA.
- John T. MacDonald Foundation Department of Human Genetics, University of Miami, Miller School of Medicine, Miami, Florida, USA.
Förderung
- NIA NIH HHS
- National Institute on Aging
Zitieren
APA
Li, Y. J., La, J. O., Naj, A., & Martin, E. R. (2026). Leveraging genetic propensity to identify modifiable factors for the age at onset of Alzheimer's disease. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71111
Vancouver
Li YJ, La JO, Naj A, Martin ER. Leveraging genetic propensity to identify modifiable factors for the age at onset of Alzheimer's disease. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71111
BibTeX
@article{Li2026,
author = {Li, Yi-Ju and La, Jong Ok and Naj, Adam and Martin, Eden R},
title = {Leveraging genetic propensity to identify modifiable factors for the age at onset of Alzheimer's disease},
journal = {Alzheimer's & Dementia},
year = {2026},
doi = {10.1002/alz.71111}
}
EUVIMED